Resetting microbiota by Lactobacillus reuteri inhibits T reg deficiency–induced autoimmunity via adenosine A2A receptors
Open accessThe DOI matches its Crossref record; 89 of the 89 references it cites were found in a registry or an index.
Abstract
Regulatory T (T reg) cell deficiency causes lethal, CD4+ T cell–driven autoimmune diseases. Stem cell transplantation is used to treat these diseases, but this procedure is limited by the availability of a suitable donor. The intestinal microbiota drives host immune homeostasis by regulating the differentiation and expansion of T reg, Th1, and Th2 cells. It is currently unclear if T reg cell deficiency–mediated autoimmune disorders can be treated by targeting the enteric microbiota. Here, we demonstrate that Foxp3+ T reg cell deficiency results in gut microbial dysbiosis and autoimmunity over the lifespan of scurfy (SF) mouse. Remodeling microbiota with Lactobacillus reuteri prolonged survival and reduced multiorgan inflammation in SF mice. L. reuteri changed the metabolomic profile disrupted by T reg cell deficiency, and a major effect was to restore levels of the purine metabolite inosine. Feeding inosine itself prolonged life and inhibited multiorgan inflammation by reducing Th1/Th2 cells and their associated cytokines. Mechanistically, the inhibition of inosine on the differentiation of Th1 and Th2 cells in vitro depended on adenosine A2A receptors, which were also required for the efficacy of inosine and of L. reuteri in vivo. These results reveal that the microbiota–inosine–A2A receptor axis might represent a potential avenue for combatting autoimmune diseases mediated by T reg cell dysfunction.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

![Figure 2. L. reuteri early treatment modulates the intestinal microbiota in SF mice. (A) Gut microbial Shannon diversity analysis, comparing groups of WT, SF, and SF treated with L. reuteri (SFL; one-way ANOVA; n = 10–12 per group). (B) Weighted UniFrac-based three-dimensional PCoA analysis of gut microbiota of WT, SF, and SFL mice (n = 10–12 per group). (C) Nonparametric multiple dimensional scaling analysis of gut microbiota of WT, SF, and SFL mice (n = 10–12 per group). (D–F) Relative abundance of predominant bacteria (>1% in any sample) at the phylum level [D], and at the genus level (E), and relative abundance of total bacteria at genus level (F) in feces (one-way ANOVA; n = 10–12 per group). (G) Relative abundance of Lactobacillus at the species level in feces (one-way ANOVA; n = 10–12 per group). **, P < 0.01; ***, P < 0.001. SF versus WT. #, P < 0.05; ##, P < 0.01; and ###, P < 0.001. SFL versus SF. Error bars represent mean ± SEM.](https://figures.cochat.ai/paper-figures/629ff5e4f9894e32a98665c3e1997eb5/resetting-microbiota-by-i-lactobacillus-reuteri-i-inhibits-t-reg-figure-2.jpg)






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“In mice, intake of dietary carbohydrates,105 certain probiotics,140 artificial sweeteners141 and emulsifiers142 can modulate host immunity and inflammation, in part mediated by compositional changes of the gut microbiome.”
From Interaction between microbiota and immunity in health and disease (2020) · cites this paper as [140]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
QIIME allows analysis of high-throughput community sequencing data
Caporaso, J. G., Kuczynski, J., Stombaugh, J., Bittinger, K., Bushman, F. D., Costello, E. K., Fierer, N., Peña, A. G., Goodrich, J. K., Gordon, J. I., et al. (2010) · Nature Methods · doi:10.1038/nmeth.f.303 · Cited by 34,887 · cited 1×
“Gut microbial dysbiosis can lead to autoimmune diseases, including IBD, autoimmune arthritis, type I diabetes, and experimental autoimmune encephalomyelitis (EAE; Cerf-Bensussan and Gaboriau-Routhiau, 2010; Wu and Wu, 2012; Markle et al., 2013).”
BackgroundDiet rapidly and reproducibly alters the human gut microbiome
David, L. A., Maurice, C. F., Carmody, R. N., Gootenberg, D. B., Button, J. E., Wolfe, B. E., Ling, A. V., Devlin, A. S., Varma, Y., Fischbach, M. A., et al. (2014) · Nature · doi:10.1038/nature12820 · Cited by 10,100
Dose translation from animal to human studies revisited.
Reagan‐Shaw, S., Nihal, M., & Ahmad, N. (2008) · The FASEB Journal · doi:10.1096/fj.07-9574lsf · Cited by 6,524
Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells
Furusawa, Y., Obata, Y., Fukuda, S., Endo, T. A., Nakato, G., Takahashi, D., Nakanishi, Y., Uetake, C., Kato, K., Kato, T., et al. (2013) · Nature · doi:10.1038/nature12721 · Cited by 5,549 · cited 1×
“Methods focusing on target identification of bioactive small molecules will further provide tools to elucidate the molecular details of inosine–A2A interaction (Futamura et al., 2013; Ziegler et al., 2013).”
BackgroundRole of the microbiota in immunity and inflammation.
Belkaid, Y., & Hand, T. W. (2014) · Cell · doi:10.1016/j.cell.2014.03.011 · Cited by 5,385 · cited 3×
“…by T reg cell deficiency could be reprogramed by oral administration of L. reuteri. remodeling gut microbiota by L. reuteri suppresses autoimmunity induced by t reg cell deficiency Gut microbiota play an important role in regulating host immune homeostasis (Wu and Wu, 2012; Belkaid and Hand, 2014).”
BackgroundMeijer, L., Nelson, D. J., Riazanski, V., Gabdoulkhakova, A. G., Hery-Arnaud, G., Le Berre, R., Loaëc, N., Oumata, N., Galons, H., Nowak, E., et al. (2016) · Journal of Innate Immunity · doi:10.1159/000444256 · Cited by 4,992
Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation
Arpaia, N., Campbell, C., Fan, X., Dikiy, S., van der Veeken, J., deRoos, P., Liu, H., Cross, J. R., Pfeffer, K., Coffer, P. J., et al. (2013) · Nature · doi:10.1038/nature12726 · Cited by 4,838
Host-gut microbiota metabolic interactions
Nicholson, J. K., Holmes, E., Kinross, J., Burcelin, R., Gibson, G., Jia, W., & Pettersson, S. (2012) · Science · doi:10.1126/science.1223813 · Cited by 4,760 · cited 1×
“To address this hypothesis, we measured the villus height and crypt depth, and we examined the expression levels of the intestinal nucleoside transporters equilibrative nucleoside transporter 1 (ENT1) and concentrative nucleoside transporter 2 (CNT2; Ward et al., 2000; Okada et al., 2006).”
MethodInteractions Between the Microbiota and the Immune System
Hooper, L. V., Littman, D. R., & Macpherson, A. J. (2012) · Science · doi:10.1126/science.1223490 · Cited by 4,173
Bennett, C. L., Christie, J., Ramsdell, F., Brunkow, M. E., Ferguson, P. J., Whitesell, L., Kelly, T. E., Saulsbury, F. T., Chance, P. F., & Ochs, H. D. (2001) · Nature Genetics · doi:10.1038/83713 · Cited by 3,402
Human Genetics Shape the Gut Microbiome
Goodrich, J. K., Waters, J. L., Poole, A. C., Sutter, J. L., Koren, O., Blekhman, R., Beaumont, M., Van Treuren, W., Knight, R., Bell, J. T., et al. (2014) · Cell · doi:10.1016/j.cell.2014.09.053 · Cited by 3,164
Deaglio, S., Dwyer, K. M., Gao, W., Friedman, D., Usheva, A., Erat, A., Chen, J.-F., Enjyoji, K., Linden, J., Oukka, M., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20062512 · Cited by 2,470
Round, J. L., & Mazmanian, S. K. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909122107 · Cited by 2,233
Sex differences in the gut microbiome drive hormone-dependent regulation of autoimmunity
Markle, J. G. M., Frank, D. N., Mortin-Toth, S., Robertson, C. E., Feazel, L. M., Rolle-Kampczyk, U., von Bergen, M., McCoy, K. D., Macpherson, A. J., & Danska, J. S. (2013) · Science · doi:10.1126/science.1233521 · Cited by 2,025 · cited 1×
“…in the α-chain of the IL-2 receptor (CD25), signal transducer and activator of transcription 5b (STAT5b), Itchy E3 ubiquitin protein ligase (ITCH), STAT1, cytotoxic T-lymphocyte–associated protein 4 (CTLA4), and Wiskott-Aldrich syndrome (WAS; Massaad et al., 2013; Verbsky and Chatila, 2013).”
BackgroundPlasticity of CD4+ T Cell Lineage Differentiation
Zhou, L., Chong, M. M. W., & Littman, D. R. (2009) · Immunity · doi:10.1016/j.immuni.2009.05.001 · Cited by 1,551
The role of gut microbiota in immune homeostasis and autoimmunity
Wu, H.-J., & Wu, E. (2012) · Gut Microbes · doi:10.4161/gmic.19320 · Cited by 1,426
Lupp, C., Robertson, M. L., Wickham, M. E., Sekirov, I., Champion, O. L., Gaynor, E. C., & Finlay, B. B. (2007) · Cell Host & Microbe · doi:10.1016/j.chom.2007.06.010 · Cited by 1,307 · cited 1×
“Intestinal microbial dysbiosis can develop as a result of an abnormal diet, infection, inflammation, and altered host genetics (Lupp et al., 2007; David et al., 2014; Goodrich et al., 2014; Lukens et al., 2014).”
BackgroundCD39 and CD73 in immunity and inflammation
Antonioli, L., Pacher, P., Vizi, E. S., & Haskó, G. (2013) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2013.03.005 · Cited by 1,263 · cited 4×
“the therapeutic effect of inosine on t reg cell–deficient SF mice is mediated by A2A receptors T reg cells control Th1/Th2 mediated by A2A receptors (Deaglio et al., 2007; Csóka et al., 2008; Antonioli et al., 2013).”
BackgroundInfluentialHemarajata, P., & Versalovic, J. (2013) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756283x12459294 · Cited by 1,083
Agonist-bound adenosine A2A receptor structures reveal common features of GPCR activation
Lebon, G., Warne, T., Edwards, P. C., Bennett, K., Langmead, C. J., Leslie, A. G. W., & Tate, C. G. (2011) · Nature · doi:10.1038/nature10136 · Cited by 873
Structure of an Agonist-Bound Human A 2A Adenosine Receptor
Xu, F., Wu, H., Katritch, V., Han, G. W., Jacobson, K. A., Gao, Z.-G., Cherezov, V., & Stevens, R. C. (2011) · Science · doi:10.1126/science.1202793 · Cited by 813
Rudensky, A. Y. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01018.x · Cited by 765 · cited 1×
“To control inflammation or allergy, T reg cells exert a dominantly negative regulation of other Th subsets (Th1/Th2), which are proinflammatory (Rudensky, 2011).”
BackgroundGut microbiota–generated metabolites in animal health and disease
Lee, W.-J., & Hase, K. (2014) · Nature Chemical Biology · doi:10.1038/nchembio.1535 · Cited by 756 · cited 1×
“…commensal bacterial metabolism play a key role in microbe–host interactions (Nicholson et al., 111JEM Vol. 214, No. 1 2012; Dorrestein et al., 2014; Lee and Hase, 2014), we analyzed metabolomic profiles of plasma and feces obtained from WT, SF, and SF with L. reuteri given before overt symptoms…”
MethodThe Diagnostic Approach to Monogenic Very Early Onset Inflammatory Bowel Disease
Uhlig, H. H., Schwerd, T., Koletzko, S., Shah, N., Kammermeier, J., Elkadri, A., Ouahed, J., Wilson, D. C., Travis, S. P., Turner, D., et al. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.07.023 · Cited by 715 · cited 1×
“L. reuteri DSM17938 is effective in treating and preventing diseases that affect infants and children, including necrotizing enterocolitis, diarrhea, and infantile colic (Urbańska and Szajewska, 2014).”
BackgroundThe immune system and the gut microbiota: friends or foes?
Cerf-Bensussan, N., & Gaboriau-Routhiau, V. (2010) · Nature Reviews Immunology · doi:10.1038/nri2850 · Cited by 704
Mack, D. R., Ahrne, S., Hyde, L., Wei, S., & Hollingsworth, M. A. (2003) · Gut · doi:10.1136/gut.52.6.827 · Cited by 666 · cited 3×
“La DDS has been shown to lack the properties of adherence to epithelial cells, induction of mucin expression by intestinal epithelial cells, inhibition of enteropathogenic E. coli epithelial cell adherence, and inhibition of NF-κB (Mack et al., 2003; Liu et al., 2012).”
BackgroundAdenosine, Adenosine Receptors and the Actions of Caffeine
Fredholm, B. B. (1995) · Pharmacology & Toxicology · doi:10.1111/j.1600-0773.1995.tb00111.x · Cited by 597
Kawamoto, S., Maruya, M., Kato, L. M., Suda, W., Atarashi, K., Doi, Y., Tsutsui, Y., Qin, H., Honda, K., Okada, T., et al. (2014) · Immunity · doi:10.1016/j.immuni.2014.05.016 · Cited by 531
Turnover of adenosine in plasma of human and dog blood
Moser, G. H., Schrader, J., & Deussen, A. (1989) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1989.256.4.c799 · Cited by 529
An update on the use and investigation of probiotics in health and disease
Sanders, M. E., Guarner, F., Guerrant, R., Holt, P. R., Quigley, E. M., Sartor, R. B., Sherman, P. M., & Mayer, E. A. (2013) · Gut · doi:10.1136/gutjnl-2012-302504 · Cited by 503
Foxo proteins cooperatively control the differentiation of Foxp3+ regulatory T cells
Ouyang, W., Beckett, O., Ma, Q., Paik, J.-H., DePinho, R. A., & Li, M. O. (2010) · Nature Immunology · doi:10.1038/ni.1884 · Cited by 467 · cited 1×
“Forkhead box protein 3 (Foxp3) is a major transcription factor that is associated with T reg cell development and function (Ouyang et al., 2010).”
BackgroundTarget Identification for Small Bioactive Molecules: Finding the Needle in the Haystack
Ziegler, S., Pries, V., Hedberg, C., & Waldmann, H. (2013) · Angewandte Chemie International Edition · doi:10.1002/anie.201208749 · Cited by 466
Fredholm, B. B., Irenius, E., Kull, B., & Schulte, G. (2001) · Biochemical Pharmacology · doi:10.1016/s0006-2952(00)00570-0 · Cited by 430
X-linked lymphoreticular disease in the scurfy (sf) mutant mouse.
Godfrey, V., Wilkinson, J. E., & Russell, L. B. (1991) · PubMed · Cited by 405
Wiskott‐Aldrich syndrome: a comprehensive review
Massaad, M. J., Ramesh, N., & Geha, R. S. (2013) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12049 · Cited by 349 · cited 1×
“Adenosine would be rapidly cleared in plasma in vivo (in ∼30 s (Möser et al., 1989), whereas inosine has a much longer in vivo half-life than adenosine (∼15 h; Viegas et al., 2000).”
BackgroundHaskó, G., Kuhel, D. G., Németh, Z. H., Mabley, J. G., Stachlewitz, R. F., Virág, L., Lohinai, Z., Southan, G. J., Salzman, A. L., & Szabó, C. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.2.1013 · Cited by 334 · cited 1×
“Previous studies demonstrated that inosine treatment reduces levels of inflammatory cytokines produced by LPS-stimulated macrophages in murine models of endotoxic shock (Haskó et al., 2000).”
BackgroundSpinler, J. K., Taweechotipatr, M., Rognerud, C. L., Ou, C. N., Tumwasorn, S., & Versalovic, J. (2008) · Anaerobe · doi:10.1016/j.anaerobe.2008.02.001 · Cited by 332
Walter, J., Britton, R. A., & Roos, S. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1000099107 · Cited by 325
Self-citationFinding the Missing Links among Metabolites, Microbes, and the Host
Dorrestein, P. C., Mazmanian, S. K., & Knight, R. (2014) · Immunity · doi:10.1016/j.immuni.2014.05.015 · Cited by 317
Dietary modulation of the microbiome affects autoinflammatory disease
Lukens, J. R., Gurung, P., Vogel, P., Johnson, G. R., Carter, R. A., McGoldrick, D. J., Bandi, S. R., Calabrese, C. R., Walle, L. V., Lamkanfi, M., et al. (2014) · Nature · doi:10.1038/nature13788 · Cited by 314
Ward, J. L., Sherali, A., Mo, Z.-P., & Tse, C.-M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.12.8375 · Cited by 311
Immunomodulatory and neuroprotective effects of inosine
Haskó, G., Sitkovsky, M. V., & Szabó, C. (2004) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2004.01.006 · Cited by 308
Role of commercial probiotic strains against human pathogen adhesion to intestinal mucus
Collado, M. C., Meriluoto, J., & Salminen, S. (2007) · Letters in Applied Microbiology · doi:10.1111/j.1472-765x.2007.02212.x · Cited by 303
Inosine binds to A3 adenosine receptors and stimulates mast cell degranulation.
Jin, X., Shepherd, R. K., Duling, B. R., & Linden, J. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119833 · Cited by 251 · cited 3×
“Previous studies showed that inosine has no capacity to activate A2A or displace the binding of a high-affinity agonist to A2A (Fredholm, 1995; Jin et al., 1997; Fredholm et al., 2001), which may be caused by its low affinity for the A2A receptor, to low levels of A2A expression, or to differential cell types that aff…”
BackgroundSchwarzschild, M. A., Ascherio, A., Beal, M. F., Cudkowicz, M. E., Curhan, G. C., Hare, J. M., Hooper, D. C., Kieburtz, K. D., Macklin, E. A., Oakes, D., et al. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2013.5528 · Cited by 243
Csóka, B., Himer, L., Selmeczy, Z., Vizi, E. S., Pacher, P., Ledent, C., Deitch, E. A., Spolarics, Z., Németh, Z. H., & Haskü, G. (2008) · The FASEB Journal · doi:10.1096/fj.08-107458 · Cited by 197 · cited 4×
“the therapeutic effect of inosine on t reg cell–deficient SF mice is mediated by A2A receptors T reg cells control Th1/Th2 mediated by A2A receptors (Deaglio et al., 2007; Csóka et al., 2008; Antonioli et al., 2013).”
BackgroundInfluentialAltered fecal microflora and increased fecal calprotectin in infants with colic
Rhoads, J. M., Fatheree, N. Y., Norori, J., Liu, Y., Lucke, J. F., Tyson, J. E., & Ferris, M. J. (2009) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2009.05.012 · Cited by 190 · cited 2×
“L. reuteri modulates the abnormal microbial communities associated with these diseases (Mai et al., 2006; Rhoads et al., 2009; Torrazza and Neu, 2013; Patel and Denning, 2015).”
BackgroundSelf-citationCD4+CD8- T cells are the effector cells in disease pathogenesis in the scurfy ( sf ) mouse.
Blair, P. J., Bultman, S. J., Haas, J. C., Rouse, B. T., Wilkinson, J. E., & Godfrey, V. L. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.153.8.3764 · Cited by 185
Liu, Y., Fatheree, N. Y., Mangalat, N., & Rhoads, J. M. (2012) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00266.2011 · Cited by 182
Self-citationGodfrey, V. L., Wilkinson, J. E., Rinchik, E. M., & Russell, L. B. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.13.5528 · Cited by 179 · cited 1×
“The scurfy (SF) mouse, which bears a mutation in the Foxp3 gene, displays a similar clinical phenotype, with early onset dermatitis, progressive multiorgan inflammation, and death within the first month of life caused by a lymphoproliferative syndrome (Godfrey et al., 1991a,b; Sharma et al., 2009).”
BackgroundVerbsky, J. W., & Chatila, T. A. (2013) · Current Opinion in Pediatrics · doi:10.1097/mop.0000000000000029 · Cited by 172
Intestinal microbiota and its relationship with necrotizing enterocolitis
Patel, R. M., & Denning, P. W. (2015) · Pediatric Research · doi:10.1038/pr.2015.97 · Cited by 172
The role of gut microbiota in programming the immune phenotype
Weng, M., & Walker, W. A. (2013) · Journal of Developmental Origins of Health and Disease · doi:10.1017/s2040174412000712 · Cited by 171 · cited 1×
“The intestinal microbiota drives host immune homeostasis by regulating the differentiation and expansion of T reg cells (Round and Mazmanian, 2010; Arpaia et al., 2013; Furusawa et al., 2013; Weng and Walker, 2013; Belkaid and Hand, 2014).”
BackgroundSuccessful bone marrow transplantation for IPEX syndrome after reduced-intensity conditioning
Rao, A., Kamani, N., Filipovich, A., Lee, S. M., Davies, S. M., Dalal, J., & Shenoy, S. (2007) · Blood · doi:10.1182/blood-2006-05-025072 · Cited by 168 · cited 2×
“Transplantation of donor T reg cells and stem cells is promising, but the procedure is limited by the availability of a suitable donor; and the ultimate outcome can be fatal or associated with chronic health problems (Rao et al., 2007; Seidel et al., 2009; Burroughs et al., 2010; Nademi et al., 2014).”
BackgroundWelihinda, A. A., Kaur, M., Greene, K., Zhai, Y., & Amento, E. P. (2016) · Cellular Signalling · doi:10.1016/j.cellsig.2016.02.010 · Cited by 152 · cited 4×
“Inosine is an agonist of adenosine receptors, which are required for the protective effects of inosine in vivo (Gomez and Sitkovsky, 2003; Haskó et al., 2004; Nascimento et al., 2010; Rahimian et al., 2010; da Rocha Lapa et al., 2013; Muto et al., 2014; Welihinda et al., 2016).”
BackgroundInfluentialThe Altered Gut Microbiome and Necrotizing Enterocolitis
Torrazza, R. M., & Neu, J. (2013) · Clinics in Perinatology · doi:10.1016/j.clp.2012.12.009 · Cited by 124
Gomez, G., & Sitkovsky, M. V. (2003) · Blood · doi:10.1182/blood-2002-11-3624 · Cited by 124
Urbańska, M., & Szajewska, H. (2014) · European Journal of Pediatrics · doi:10.1007/s00431-014-2328-0 · Cited by 123
Chinen, T., Volchkov, P. Y., Chervonsky, A. V., & Rudensky, A. Y. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20101235 · Cited by 120
Disease in the scurfy (sf) mouse is associated with overexpression of cytokine genes
Kanangat, S., Blair, P., Reddy, R., Deheshia, M., Godfrey, V., Rouse, B. T., & Wilkinson, E. (1996) · European Journal of Immunology · doi:10.1002/eji.1830260125 · Cited by 118
Histamine‐2 Receptor Blockers Alter the Fecal Microbiota in Premature Infants
Gupta, R. W., Tran, L., Norori, J., Ferris, M. J., Eren, A. M., Taylor, C. M., Dowd, S. E., & Penn, D. (2013) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0b013e318282a8c2 · Cited by 106 · cited 2×
“Clinical management has not been updated since 1993 (Hannibal and Torgerson, 2011).”
BackgroundSelf-citationInosine reduces inflammation and improves survival in a murine model of colitis
Mabley, J. G., Pacher, P., Liaudet, L., Soriano, F. G., Haskó, G., Marton, A., Szabó, C., & Salzman, A. L. (2003) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00060.2002 · Cited by 106 · cited 3×
“Inosine also attenuates the course of chronic autoimmune inflammatory diseases including type I diabetes (Mabley et al., 2003b) and experimental colitis (Mabley et al., 2003a; Rahimian et al., 2010), in association with a reduction of the production of proinflammatory cytokines and chemokines.”
BackgroundHe, B., Nohara, K., Ajami, N. J., Michalek, R. D., Tian, X., Wong, M., Losee-Olson, S. H., Petrosino, J. F., Yoo, S. H., Shimomura, K., et al. (2015) · Scientific Reports · doi:10.1038/srep10604 · Cited by 88 · cited 2×
“The metabolomic data were analyzed by pattern recognition analyses (unsupervised principal component analysis and Heat-map), revealing the biochemical perturbations induced by T reg cell deficiency or L. reuteri treatment, as previously described (He et al., 2015).”
MethodSelf-citationLiu, Y., Fatheree, N. Y., Dingle, B. M., Tran, D. Q., & Rhoads, J. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056547 · Cited by 87
Self-citationOral administration of inosine produces antidepressant-like effects in mice
Muto, J., Lee, H., Lee, H., Uwaya, A., Park, J., Nakajima, S., Nagata, K., Ohno, M., Ohsawa, I., & Mikami, T. (2014) · Scientific Reports · doi:10.1038/srep04199 · Cited by 86 · cited 1×
“Therefore, we could not rule out that the gut environment activates these enzymatic functions to help generate more inosine to be absorbed (Muzny et al., 2011).”
BackgroundLapa, F. D. R., da Silva, M. D., Cabrini, D. A., & Santos, A. R. S. (2012) · Purinergic Signalling · doi:10.1007/s11302-012-9299-2 · Cited by 85 · cited 6×
“However, several other findings indicate the protective effects of inosine are mediated by interaction with adenosine A2A receptors (Gomez and Sitkovsky, 2003; Mabley et al., 2008; Rahimian et al., 2010; da Rocha Lapa et al., 2012, 2013; Muto et al., 2014).”
BackgroundInfluentialTarget identification of small molecules based on chemical biology approaches
Futamura, Y., Muroi, M., & Osada, H. (2013) · Molecular BioSystems · doi:10.1039/c2mb25468a · Cited by 82
Roelofsen, H., Priebe, M., & Vonk, R. (2010) · Beneficial Microbes · doi:10.3920/bm2010.0028 · Cited by 80 · cited 1×
“Metabolites produced by bacteria promote or suppress immune cell functions (Roelofsen et al., 2010; Arpaia et al., 2013; Furusawa et al., 2013).”
BackgroundLiu, Y., Tran, D. Q., Fatheree, N. Y., & Marc Rhoads, J. (2014) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00038.2014 · Cited by 78 · cited 1×
“Intestinal microbial dysbiosis can develop as a result of an abnormal diet, infection, inflammation, and altered host genetics (Lupp et al., 2007; David et al., 2014; Goodrich et al., 2014; Lukens et al., 2014).”
BackgroundSelf-citationSeidel, M. G., Fritsch, G., Lion, T., Jürgens, B., Heitger, A., Bacchetta, R., Lawitschka, Á., Peters, C., Gadner, H., & Matthes‐Martin, S. (2009) · Blood · doi:10.1182/blood-2009-02-206359 · Cited by 77 · cited 2×
“The scurfy (SF) mouse, which bears a mutation in the Foxp3 gene, displays a similar clinical phenotype, with early onset dermatitis, progressive multiorgan inflammation, and death within the first month of life caused by a lymphoproliferative syndrome (Godfrey et al., 1991a,b; Sharma et al., 2009).”
BackgroundResultdo Nascimento, F. P., Figueredo, S. M., Marcon, R., Martins, D. F., Macedo, S. J., Lima, D. A. N., Almeida, R. C., Ostroski, R. M., Rodrigues, A. L. S., & Santos, A. R. S. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.166058 · Cited by 69
Burroughs, L. M., Torgerson, T. R., Storb, R. F., Carpenter, P. A., Rawlings, D. J., Sanders, J. E., Scharenberg, A. M., Skoda‐Smith, S., Englund, J. A., Ochs, H. D., et al. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.05.021 · Cited by 62
Lapa, F. D. R., de Oliveira, A. P. L., Acceturi, B. G., Martins, I. D. O., Domingos, H. V., Cabrini, D. A., de Lima, W. T., & Santos, A. R. S. (2013) · Purinergic Signalling · doi:10.1007/s11302-013-9351-x · Cited by 55 · cited 6×
“However, several other findings indicate the protective effects of inosine are mediated by interaction with adenosine A2A receptors (Gomez and Sitkovsky, 2003; Mabley et al., 2008; Rahimian et al., 2010; da Rocha Lapa et al., 2012, 2013; Muto et al., 2014).”
BackgroundInfluentialMabley, J. G., Rabinovitch, A., Suarez‐Pinzon, W. L., Haskó, G., Pacher, P., Power, R. F., Southan, G. J., Salzman, A. L., & Szabó, C. (2003) · Molecular Medicine · doi:10.2119/2003-00016.mabley · Cited by 52
Okou, D. T., Mondal, K., Faubion, W. A., Kobrynski, L. J., Denson, L. A., Mulle, J. G., Ramachandran, D., Xiong, Y., Svingen, P. A., Patel, V., et al. (2014) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000000302 · Cited by 51
Rahimian, R., Fakhfouri, G., Daneshmand, A., Mohammadi, H., Bahremand, A., Rasouli, M. R., Mousavizadeh, K., & Dehpour, A. R. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.09.044 · Cited by 48 · cited 4×
“Inosine also attenuates the course of chronic autoimmune inflammatory diseases including type I diabetes (Mabley et al., 2003b) and experimental colitis (Mabley et al., 2003a; Rahimian et al., 2010), in association with a reduction of the production of proinflammatory cytokines and chemokines.”
BackgroundInfluentialSharma, R., Sharma, P. R., Kim, Y., Leitinger, N., Lee, J. K., Fu, S. M., & Ju, S. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1002677 · Cited by 47
Type‐1 immunity drives early lethality in scurfy mice
Suscovich, T. J., Perdue, N., & Campbell, D. (2012) · European Journal of Immunology · doi:10.1002/eji.201242391 · Cited by 41
Viegas, T. X., OMURA, G. A., Stoltz, R. R., & Kisicki, J. C. (2000) · The Journal of Clinical Pharmacology · doi:10.1177/00912700022008991 · Cited by 41
Nademi, Z., Slatter, M. A., Gambineri, E., Mannurita, S. C., Barge, D., Hodges, S., Bunn, S. K., Thomas, J., Haugk, B., Hambleton, S., et al. (2013) · Bone Marrow Transplantation · doi:10.1038/bmt.2013.181 · Cited by 40 · cited 1×
“Inosine is an agonist of adenosine receptors, which are required for the protective effects of inosine in vivo (Gomez and Sitkovsky, 2003; Haskó et al., 2004; Nascimento et al., 2010; Rahimian et al., 2010; da Rocha Lapa et al., 2013; Muto et al., 2014; Welihinda et al., 2016).”
BackgroundRegulation of multi-organ inflammation in the regulatory T cell-deficient scurfy mice
Sharma, R., Sung, S. J., Fu, S. M., & Ju, S. (2009) · Journal of Biomedical Science · doi:10.1186/1423-0127-16-20 · Cited by 39 · cited 2×
“The scurfy (SF) mouse, which bears a mutation in the Foxp3 gene, displays a similar clinical phenotype, with early onset dermatitis, progressive multiorgan inflammation, and death within the first month of life caused by a lymphoproliferative syndrome (Godfrey et al., 1991a,b; Sharma et al., 2009).”
BackgroundResultMonitoring of Stool Microbiota in Subjects with Diarrhea Indicates Distortions in Composition
Mai, V., Braden, C. R., Heckendorf, J., Pironis, B., & Hirshon, J. M. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.01542-06 · Cited by 36 · cited 1×
“Gut microbial dysbiosis can lead to autoimmune diseases, including IBD, autoimmune arthritis, type I diabetes, and experimental autoimmune encephalomyelitis (EAE; Cerf-Bensussan and Gaboriau-Routhiau, 2010; Wu and Wu, 2012; Markle et al., 2013).”
BackgroundBarış, S., Schulze, I., Ozen, A. O., Karakoç-Aydıner, E., Altuncu, E., Karasu, G., Öztürk, M., Lorenz, M. R., Schwarz, K., Vraetz, T., et al. (2014) · Journal of Clinical Immunology · doi:10.1007/s10875-014-0059-7 · Cited by 35 · cited 2×
“, 2012), similar to what is seen in patients with IPEX syndrome (Zennaro et al., 2012; Baris et al., 2014).”
ResultZennaro, D., Scala, E., Pomponi, D., Caprini, E., Arcelli, D., Gambineri, E., Russo, G., & Mari, A. (2011) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2011.04492.x · Cited by 25
Protective Effects of Inosine on Mice Subjected to Lethal Total-body Ionizing Irradiation
Hou, B., Zhi-Wei, X. U., Yang, C., Gao, Y., Zhao, S.-F., & Zhang, C. (2007) · Journal of Radiation Research · doi:10.1269/jrr.06067 · Cited by 24
Okada, M., Suzuki, K., Nakashima, M., Nakanishi, T., & Fujioka, N. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.12.013 · Cited by 14
Mabley, J. G., Pacher, P., Murthy, K. G. K., Williams, W., Southan, G. J., Salzman, A. L., & Szabó, C. (2008) · Journal of Endocrinology · doi:10.1677/joe-07-0511 · Cited by 13 · cited 2×
“La DDS has been shown to lack the properties of adherence to epithelial cells, induction of mucin expression by intestinal epithelial cells, inhibition of enteropathogenic E. coli epithelial cell adherence, and inhibition of NF-κB (Mack et al., 2003; Liu et al., 2012).”
BackgroundKolassa, N., Stengg, R., & Turnheim, K. (1977) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y77-143 · Cited by 9
Ra, P., Adam, M. P., Hh, A., Se, W., Amemiya, A., Ljh, B., Bird, T. D., Ct, F., Mefford, H. C., Rjh, S., et al. (2016) · Cited by 1
Cited by
Interaction between microbiota and immunity in health and disease
Zheng, D., Liwinski, T., & Elinav, E. (2020) · Cell Research · doi:10.1038/s41422-020-0332-7 · Cited by 3,947
You are what you eat: Diet, health and the gut microbiota
Zmora, N., Suez, J., & Elinav, E. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-018-0061-2 · Cited by 1,792
Microbiome-derived inosine modulates response to checkpoint inhibitor immunotherapy
Mager, L. F., Burkhard, R., Pett, N., Cooke, N. C. A., Brown, K., Ramay, H., Paik, S., Stagg, J., Groves, R. A., Gallo, M., et al. (2020) · Science · doi:10.1126/science.abc3421 · Cited by 1,407
Role of Lactobacillus reuteri in Human Health and Diseases
Mu, Q., Tavella, V. J., & Luo, X. M. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.00757 · Cited by 744
“A good example is L. reuteri-mediated suppression of Th1/Th2 responses in Treg-deficient mice (He et al., 2017).”
BackgroundResultThe adenosine pathway in immuno-oncology
Allard, B., Allard, D., Buisseret, L., & Stagg, J. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-0382-2 · Cited by 586
Metadata
- Authors
- He, B., Hoang, T. K., Wang, T., Ferris, M., Taylor, C. M., Tian, X., Luo, M., Tran, D. Q., Zhou, J., Tatevian, N., Luo, F., Molina, J. G., Blackburn, M. R., Gomez, T. H., Roos, S., Rhoads, J. M., & Liu, Y.
- Affiliations
- The University of Texas Health Science Center at Houston (US)
- Louisiana State University (US)
- Baylor College of Medicine (US)
- Swedish University of Agricultural Sciences (SE)
- Corresponding author
- Rhoads, J. Marc
- Liu, Yuying
- ORCID
- Venue
- Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2016-12-19
- Volume
- 214
- Issue
- 1
- Pages
- 107-123
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC5206500
- OpenAlex
- W2566314801
- Cited by
- 196
- References
- 89
- Citations by year
- 2026: 14 · 2025: 26 · 2024: 21 · 2023: 25 · 2022: 26 · 2021: 33 · 2020: 19 · 2019: 12 · 2018: 11 · 2017: 9
- FWCI
- 6.47
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- The Journal of Experimental Medicine (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Center for Complementary and Integrative Health (R01AT007083)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Keywords
- Lactobacillus reuteri, Foxp3, autoimmunity, gut microbiota, dysbiosis, adenosine A2A receptor, inosine, purine metabolism, Th1/Th2 cells, gut microbiota transplantation, CD4+ T cells
- MeSH terms
- Gastrointestinal Microbiome, Animals, Cell Differentiation, Female, Inosine, Male, Mice, Inbred C57BL, Autoimmunity, Th1 Cells, Th2 Cells, Receptor, Adenosine A2A, T-Lymphocytes, Regulatory, Mice, Limosilactobacillus reuteri, Metabolomics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.